pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
pre_registration
CLOBETASOL PROPIONATE
CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)
Ocular Pain (Eye Pain)
Glucocorticoid receptor
Laboratorios Salvat SA
0 catalysts
CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05%
CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% (CLOBETASOL PROPIONATE CREAM USP, 0.05%)
ENCUBE
0 catalysts
CLOPIDOGREL
CLOPIDOGREL (CLOPIDOGREL)
HETERO LABS LTD V
0 catalysts
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
← prev
page 76 of 271
next →
131
Pain89
Neurology1
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)
TARO
0 catalysts
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% (CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%)
TP ANDA HOLDINGS
0 catalysts
Phase 2
CLR-121125
Triple-Negative Breast Cancer (TNBC)
$CLRBCellectar Biosciences, Inc.
0 catalysts
Preclinical
CLRN1
Usher Syndrome
Akouos Inc
0 catalysts
Preclinical
CLS-014
Pancreatic Cancer
CLS Therapeutics
0 catalysts
Phase 1
CLY-124
Sickle Cell Disease
Cellarity Inc
0 catalysts
Preclinical
CM-109
Gastric Cancer
Excelmab Inc
0 catalysts
Preclinical
CM-110
Small-Cell Lung Cancer
Excelmab Inc
0 catalysts
Phase 2
CM-4612
Attention Deficit Hyperactivity Disorder (ADHD)
Curemark LLC
0 catalysts
Phase 3
CM-AT
LUMINENZ-AT
Autism Spectrum Disorder (ASD)
Curemark LLC
0 catalysts
Preclinical
CMN-008
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Benecyte Inc
0 catalysts
Phase 2
CMND-100
Alcohol Use Disorder (AUD)
$CMNDClearmind Medicine Inc.
0 catalysts
Phase 1
CMS-121
Alzheimer's Disease
Virogenics Inc
0 catalysts
Preclinical
CMTS-1
Type 2 Diabetes
Celdara Medical LLC
0 catalysts
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
0 catalysts
Preclinical
CMTX-301
Otitis Media
Clarametyx Biosciences Inc
0 catalysts
Phase 2
CN-105
Intracerebral Hemorrhage
AegisCN LLC
0 catalysts
Phase 2
CNA-3103
Metastatic Colorectal Cancer
Carina Biotech Pty Ltd
0 catalysts
Phase 2
CNP-103
Type 1 Diabetes (Juvenile Diabetes)
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNP-104
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNP-106
Myasthenia Gravis
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNS10-NPC
Amyotrophic Lateral Sclerosis
Cedars-Sinai Medical Center
0 catalysts
Phase 2
CNTX-6016
Diabetic Neuropathic Pain
Centrexion Therapeutics Corp
0 catalysts
Preclinical
CNTY-813
Type 1 Diabetes (Juvenile Diabetes)
$IPSCCentury Therapeutics, Inc.
0 catalysts
Preclinical
CNX-001
Unspecified
Cannovex BV
0 catalysts
CODEINE SULFATE
CODEINE SULFATE (CODEINE SULFATE)
Hikma Pharmaceuticals Plc
0 catalysts
COLLAGENASE SANTYL
COLLAGENASE SANTYL (COLLAGENASE SANTYL)
SMITH AND NEPHEW
0 catalysts